Can Dietary Change Reduce Chronic Pain? What Trials Show

Diet may lower chronic pain, but it has not been shown to "rewire" pain pathways

For people with chronic pain, food is worth taking seriously. A 2021 systematic review and meta-analysis found that dietary interventions reduced self-reported pain across a range of chronic pain conditions. But the popular leap—from "diet improved pain scores" to "diet reverses central sensitization"—goes beyond the human evidence.

That distinction matters most in conditions such as fibromyalgia, where the nervous system can amplify pain signals without a proportional injury in the tissues. Neuroinflammation, gut microbiota, metabolic dysfunction, and dietary quality may all contribute. They form a plausible chain. They do not yet form a demonstrated treatment mechanism in humans.

The useful conclusion is less dramatic and more actionable: improving diet quality can be a reasonable adjunct to established pain care. It may reduce pain for some people, especially when it also supports weight loss, metabolic health, and a more manageable daily routine. It should not replace evaluation or treatment for inflammatory disease, nerve injury, endometriosis, structural joint disease, or severe pain sensitization.

What the intervention evidence actually found

The strongest evidence comes from Field et al.'s 2021 systematic review and meta-analysis. It included 43 controlled studies across 48 chronic-pain study groups, including fibromyalgia, osteoarthritis, inflammatory arthritis, chronic widespread pain, and other conditions. A subset of the groups entered the formal meta-analysis, which found a statistically significant reduction in pain outcomes with dietary intervention.

Seventeen of the 48 study groups achieved what the review defined as a clinically meaningful improvement: at least a 2-point or 33% reduction on a visual analogue scale. That is an encouraging result, but it is not a universal result. Most groups did not meet that threshold, and the available summary does not provide the pooled effect size, confidence interval, or heterogeneity statistic needed to judge the average benefit and how consistently it appeared across studies.

The interventions also did not point to one magic menu. They included elimination protocols, vegetarian or vegan diets, single-food changes, calorie or macronutrient restriction, and omega-3-focused approaches. No category showed clear superiority. This pattern suggests that shared features may matter more than a branded dietary identity: less ultra-processed food, greater nutrient density, fewer calories for people who need weight loss, or some combination of these changes.

That is a practical advantage. A person does not need to choose between becoming a Mediterranean-diet loyalist, a vegan, or a fish-oil maximalist. The evidence supports testing a sustainable whole-food pattern rather than chasing a single ingredient.

Why fibromyalgia has drawn attention

Fibromyalgia is often discussed as a centrally sensitized pain condition: pain processing becomes dysregulated, producing heightened pain sensitivity and symptoms that cannot be explained by tissue damage alone. That makes dietary patterns especially interesting, but the direct evidence remains observational.

A 2025 case-control study by Martín Pérez et al. found higher ultra-processed-food consumption and higher pro-inflammatory dietary scores in adults with fibromyalgia than in healthy controls. A separate 2024 cross-sectional questionnaire study found that greater Mediterranean-diet adherence correlated with lower fibromyalgia disease severity.

Both findings fit the intervention literature, but neither proves that diet caused the difference. More severe fibromyalgia can bring fatigue, disability, financial strain, and less capacity to cook. Those consequences could push someone toward convenience foods and away from a Mediterranean-style pattern. Reverse causation is a serious possibility, not a technical footnote.

A 2025 Mendelian-randomization analysis by Niu et al. adds a different kind of evidence: specific gut microbial taxa and plasma metabolites were potentially causally associated with fibromyalgia risk. Mendelian randomization can strengthen causal inference compared with ordinary observational studies, but it does not test a diet. Genetic proxies for microbiota can also affect disease risk through pathways unrelated to gut bacteria. The study supports a microbiome–fibromyalgia hypothesis; it does not show that changing your breakfast changes fibromyalgia risk or pain.

A plausible mechanism is not a measured mechanism

Chronic pain can involve activation of microglia and astrocytes, along with inflammatory mediators such as TNF-alpha, IL-6, IL-1beta, prostaglandin E2, CCL2, CXCL1, and nerve growth factor. These processes can contribute to central sensitization, allodynia, and hyperalgesia. A 2024 mechanistic review describes this neuroinflammatory transition from acute to chronic pain.

Diet could plausibly affect this biology through systemic low-grade inflammation, adipose tissue, gut microbial metabolites, intestinal permeability, and immune signaling. Reviews of the microbiome and pain and the gut–neuroinflammation–central-sensitization pathway lay out that hypothesis in detail.

Yet no dietary intervention in this evidence base measured whether diet changed quantitative sensory testing thresholds, wind-up ratios, dorsal-horn excitability, Central Sensitization Inventory scores, substance P, BDNF, or comparable central-sensitization outcomes. Nor did these trials trace a full chain from dietary change to gut-permeability markers or short-chain fatty acids to pain relief. The mechanism is biologically credible, but it remains unproven in living humans.

Different pain conditions need different expectations

Dietary research extends beyond fibromyalgia and musculoskeletal pain. In osteoarthritis, nutritional approaches may influence inflammatory cytokines, oxidative stress, and metabolic factors, according to a 2025 mechanistic review. But weight loss can also reduce joint loading, so an improvement in knee pain does not identify dietary inflammation as the cause.

Endometriosis provides another plausible target because chronic pelvic pain can involve inflammatory, hormonal, and immune mechanisms. A 2025 narrative review discusses Mediterranean-style, anti-inflammatory, and other dietary approaches, but randomized trial evidence remains sparse. That means diet may be a useful complement to hormonal therapy, surgery, and pain management—not a substitute supported by high-certainty evidence.

Irritable bowel syndrome offers a caution against universal prescriptions. It is a gut-brain disorder with visceral pain, yet a 2025 review concluded that no single diet works for everyone. Low-FODMAP eating may provide short-term relief for some people, while long-term restriction can raise concerns about microbiota diversity. Pain biology is heterogeneous; a diet that helps one condition or person may be irrelevant to another.

What limits confidence in dietary pain trials

• Participants know what they are eating. Dietary trials cannot fully blind participants, and pain outcomes commonly rely on self-reported visual analogue or numerical rating scales. Expectation effects are difficult to separate from a true dietary effect.
• Weight loss is a competing explanation. Calorie restriction and BMI reduction can lower mechanical joint stress and systemic inflammation. Many interventions change both calories and food quality.
• Observational fibromyalgia studies cannot establish direction. Higher pain burden may worsen diet quality rather than result from it.
• Mediterranean-diet trial evidence is thinner than its reputation. It appeared in only two of the 48 study groups in Field et al.'s review, despite being the pattern most likely to be recommended in practice.
• Clinical guidance has not caught up. A 2025 review of meta-inflammation in chronic pain notes that dietary approaches remain underrepresented in chronic-pain management guidelines.

A sensible way to use this evidence

Start with a pattern you can sustain: reduce ultra-processed foods, eat a wider variety of minimally processed plant foods, include adequate protein, and favor omega-3-rich foods such as fatty fish when they fit your diet and medical needs. If weight reduction is appropriate, treat it as a potentially meaningful pain intervention in its own right.

Use a simple pain and function log while making one major dietary change at a time. Track pain severity, sleep, activity tolerance, bowel symptoms, and medication use. This will not prove a mechanism, but it can tell you whether the change helps your life. Avoid highly restrictive elimination diets unless there is a clear reason and a plan to reintroduce foods; an impressive food list is not the same thing as evidence.

Dietary improvement has a credible, low-risk role in chronic pain management. The evidence supports modest optimism about pain scores, not claims that food has already reversed central sensitization in humans.

The field's next useful trials should measure pain, function, diet adherence, weight change, microbiome and permeability markers, and validated central-sensitization outcomes in the same participants. Until then, improve diet because the clinical evidence says it may help pain and the broader health case is strong—not because anyone has proved that a salad can reboot the spinal cord.